Capital Stock Repurchase Plan Transactions

3 Months Ended

Mar. 31, 2022

Capital Stock Repurchase Plan Transactions [Abstract]

Capital Stock Repurchase Plan Transactions

14.    Capital Stock Repurchase Plan Transactions

We repurchased the following capital stock:

	Three months ended March 31,
	2022		2021
Total cost of repurchased shares (in thousands)	$	27,353	$	44,768
Shares repurchased		57,500		100,000
Weighted average price per share	$	475.71	$	447.67

In May and November 2021, the Board of Directors authorized a total of $600.0 million for additional stock repurchase under Chemed’s existing share repurchase program. We currently have $174.6 million of authorization remaining under this share repurchase plan.